# Dillard'S, Inc.: financial statements, quarterly DDS · TXSE · CIK 28917 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 30 Pages: [Overview](/companies/dds.md) · [Financials](/companies/dds/financials.md) · [Filings](/companies/dds/filings.md) · [Insiders](/companies/dds/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dds/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [1,476](/filings/0000028917-24-000030.md) | [2,124 d](/filings/0000028917-26-000006.md) | [1,549](/filings/0000028917-25-000019.md) | [1,490](/filings/0000028917-25-000025.md) | [1,427](/filings/0000028917-25-000032.md) | [2,017 d](/filings/0000028917-26-000006.md) | [1,529](/filings/0000028917-26-000019.md) | [1,514](/filings/0000028917-26-000027.md) | [1,469](/filings/0000028917-25-000032.md) | [1,962 d](/filings/0000028917-26-000006.md) | [1,568](/filings/0000028917-26-000019.md) | [1,508](/filings/0000028917-26-000027.md) | | Cost of revenue | $m | [835](/filings/0000028917-24-000030.md) | [1,346 d](/filings/0000028917-26-000006.md) | [858](/filings/0000028917-25-000019.md) | [930](/filings/0000028917-25-000025.md) | [819](/filings/0000028917-25-000032.md) | [1,312 d](/filings/0000028917-26-000006.md) | [858](/filings/0000028917-26-000019.md) | [959](/filings/0000028917-26-000027.md) | [832](/filings/0000028917-25-000032.md) | [1,268 d](/filings/0000028917-26-000006.md) | [870](/filings/0000028917-26-000019.md) | [909](/filings/0000028917-26-000027.md) | | Gross profit | $m | [642](/filings/0000028917-24-000030.md) | [778 d](/filings/0000028917-26-000006.md) | [691](/filings/0000028917-25-000019.md) | [560](/filings/0000028917-25-000025.md) | [608](/filings/0000028917-25-000032.md) | [705 d](/filings/0000028917-26-000006.md) | [671](/filings/0000028917-26-000019.md) | [555](/filings/0000028917-26-000027.md) | [637](/filings/0000028917-25-000032.md) | [694 d](/filings/0000028917-26-000006.md) | [698](/filings/0000028917-26-000019.md) | [598](/filings/0000028917-26-000027.md) | | Selling, general and administrative | $m | [422](/filings/0000028917-24-000030.md) | [477 d](/filings/0000028917-26-000006.md) | [427](/filings/0000028917-25-000019.md) | [434](/filings/0000028917-25-000025.md) | [419](/filings/0000028917-25-000032.md) | [452 d](/filings/0000028917-26-000006.md) | [422](/filings/0000028917-26-000019.md) | [434](/filings/0000028917-26-000027.md) | [440](/filings/0000028917-25-000032.md) | [463 d](/filings/0000028917-26-000006.md) | [444](/filings/0000028917-26-000019.md) | [444](/filings/0000028917-26-000027.md) | | Interest expense | $m | [(1.8)](/filings/0000028917-23-000034.md) | [(3.1) d](/filings/0000028917-24-000011.md) | [(3.5)](/filings/0000028917-24-000022.md) | [9.8](/filings/0000028917-25-000025.md) | [9.6](/filings/0000028917-25-000032.md) | [10.4 d](/filings/0000028917-26-000006.md) | [10.3](/filings/0000028917-26-000019.md) | [10.1](/filings/0000028917-26-000027.md) | [10.2](/filings/0000028917-25-000032.md) | [10.4 d](/filings/0000028917-26-000006.md) | [10.5](/filings/0000028917-26-000019.md) | [10.0](/filings/0000028917-26-000027.md) | | Income tax | $m | [44.0](/filings/0000028917-24-000030.md) | [32.0 d](/filings/0000028917-26-000006.md) | [54.8](/filings/0000028917-25-000019.md) | [22.6](/filings/0000028917-25-000025.md) | [37.9](/filings/0000028917-25-000032.md) | [20.9 d](/filings/0000028917-26-000006.md) | [49.9](/filings/0000028917-26-000019.md) | [21.8](/filings/0000028917-26-000027.md) | [39.0](/filings/0000028917-25-000032.md) | [14.1 d](/filings/0000028917-26-000006.md) | [76.8](/filings/0000028917-26-000019.md) | [29.8](/filings/0000028917-26-000027.md) | | Net income | $m | [155](/filings/0000028917-24-000030.md) | [251 d](/filings/0000028917-26-000006.md) | [180](/filings/0000028917-25-000019.md) | [74.5](/filings/0000028917-25-000025.md) | [125](/filings/0000028917-25-000032.md) | [214 d](/filings/0000028917-26-000006.md) | [164](/filings/0000028917-26-000019.md) | [72.8](/filings/0000028917-26-000027.md) | [130](/filings/0000028917-25-000032.md) | [204 d](/filings/0000028917-26-000006.md) | [251](/filings/0000028917-26-000019.md) | [97.7](/filings/0000028917-26-000027.md) | | Diluted EPS | $ per share | [9.49](/filings/0000028917-24-000030.md) | not reported | [11.09](/filings/0000028917-25-000019.md) | [4.59](/filings/0000028917-25-000025.md) | [7.73](/filings/0000028917-25-000032.md) | not reported | [10.39](/filings/0000028917-26-000019.md) | [4.66](/filings/0000028917-26-000027.md) | [8.31](/filings/0000028917-25-000032.md) | not reported | [16.04](/filings/0000028917-26-000019.md) | [6.25](/filings/0000028917-26-000027.md) | | Basic EPS | $ per share | [9.49](/filings/0000028917-24-000030.md) | not reported | [11.09](/filings/0000028917-25-000019.md) | [4.59](/filings/0000028917-25-000025.md) | [7.73](/filings/0000028917-25-000032.md) | not reported | [10.39](/filings/0000028917-26-000019.md) | [4.66](/filings/0000028917-26-000027.md) | [8.31](/filings/0000028917-25-000032.md) | not reported | [16.04](/filings/0000028917-26-000019.md) | [6.25](/filings/0000028917-26-000027.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-10-28) | FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [842](/filings/0000028917-24-000030.md) | [808](/filings/0000028917-25-000004.md) | [818](/filings/0000028917-25-000019.md) | [947](/filings/0000028917-25-000025.md) | [980](/filings/0000028917-25-000032.md) | [718](/filings/0000028917-26-000006.md) | [901](/filings/0000028917-26-000019.md) | [1,012](/filings/0000028917-26-000027.md) | [1,149](/filings/0000028917-25-000032.md) | [861](/filings/0000028917-26-000027.md) | [1,158](/filings/0000028917-26-000019.md) | [763](/filings/0000028917-26-000027.md) | | Current assets | $m | [2,666](/filings/0000028917-24-000030.md) | [2,208](/filings/0000028917-25-000004.md) | [2,708](/filings/0000028917-25-000019.md) | [2,454](/filings/0000028917-25-000025.md) | [2,942](/filings/0000028917-25-000032.md) | [2,368](/filings/0000028917-26-000006.md) | [2,768](/filings/0000028917-26-000019.md) | [2,572](/filings/0000028917-26-000027.md) | [3,169](/filings/0000028917-25-000032.md) | [2,387](/filings/0000028917-26-000027.md) | [3,047](/filings/0000028917-26-000019.md) | [2,681](/filings/0000028917-26-000027.md) | | Total assets | $m | [3,898](/filings/0000028917-24-000030.md) | [3,449](/filings/0000028917-26-000006.md) | [3,937](/filings/0000028917-25-000019.md) | [3,662](/filings/0000028917-25-000025.md) | [4,133](/filings/0000028917-25-000032.md) | [3,531](/filings/0000028917-26-000006.md) | [3,907](/filings/0000028917-26-000019.md) | [3,684](/filings/0000028917-26-000027.md) | [4,298](/filings/0000028917-25-000032.md) | [3,505](/filings/0000028917-26-000027.md) | [4,138](/filings/0000028917-26-000019.md) | [3,750](/filings/0000028917-26-000027.md) | | Current liabilities | $m | [1,202](/filings/0000028917-24-000030.md) | [828](/filings/0000028917-25-000004.md) | [1,130](/filings/0000028917-25-000019.md) | [780](/filings/0000028917-25-000025.md) | [1,237](/filings/0000028917-25-000032.md) | [835](/filings/0000028917-26-000006.md) | [1,147](/filings/0000028917-26-000019.md) | [959](/filings/0000028917-26-000027.md) | [1,445](/filings/0000028917-25-000032.md) | [902](/filings/0000028917-26-000027.md) | [1,287](/filings/0000028917-26-000019.md) | [884](/filings/0000028917-26-000027.md) | | Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [1,814](/filings/0000028917-24-000030.md) | [1,697](/filings/0000028917-26-000006.md) | [1,875](/filings/0000028917-25-000025.md) | [1,949](/filings/0000028917-25-000032.md) | [1,963](/filings/0000028917-25-000032.md) | [1,796](/filings/0000028917-26-000027.md) | [1,858](/filings/0000028917-26-000027.md) | [1,919](/filings/0000028917-26-000027.md) | [2,045](/filings/0000028917-25-000032.md) | [1,779](/filings/0000028917-26-000027.md) | [2,026](/filings/0000028917-26-000027.md) | [2,121](/filings/0000028917-26-000027.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Long-term debt: not reported - Current portion of debt: not reported - Short-term borrowings: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-10-28) | Q4 FY2023 (2024-02-03) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [49.3 d](/filings/0000028917-24-000030.md) | [436 d](/filings/0000028917-26-000006.md) | [244](/filings/0000028917-25-000019.md) | [(68.4) d](/filings/0000028917-25-000025.md) | [173 d](/filings/0000028917-25-000032.md) | [365 d](/filings/0000028917-26-000006.md) | [233](/filings/0000028917-26-000019.md) | [86.8 d](/filings/0000028917-26-000027.md) | [186 d](/filings/0000028917-25-000032.md) | [211 d](/filings/0000028917-26-000006.md) | [364](/filings/0000028917-26-000019.md) | [(37.2) d](/filings/0000028917-26-000027.md) | | Capital expenditure | $m | [40.9 d](/filings/0000028917-24-000030.md) | [28.3 d](/filings/0000028917-26-000006.md) | [35.2](/filings/0000028917-25-000019.md) | [25.9 d](/filings/0000028917-25-000025.md) | [28.1 d](/filings/0000028917-25-000032.md) | [15.4 d](/filings/0000028917-26-000006.md) | [16.9](/filings/0000028917-26-000019.md) | [26.7 d](/filings/0000028917-26-000027.md) | [30.3 d](/filings/0000028917-25-000032.md) | [19.5 d](/filings/0000028917-26-000006.md) | [17.2](/filings/0000028917-26-000019.md) | [22.3 d](/filings/0000028917-26-000027.md) | | Dividends paid | $m | [3.3 d](/filings/0000028917-24-000030.md) | [329 d](/filings/0000028917-26-000006.md) | [4.1](/filings/0000028917-25-000019.md) | [4.1 d](/filings/0000028917-25-000025.md) | [4.1 d](/filings/0000028917-25-000032.md) | [402 d](/filings/0000028917-26-000006.md) | [4.0](/filings/0000028917-26-000019.md) | [3.9 d](/filings/0000028917-26-000027.md) | [3.9 d](/filings/0000028917-25-000032.md) | [473 d](/filings/0000028917-26-000006.md) | [4.7](/filings/0000028917-26-000019.md) | [4.7 d](/filings/0000028917-26-000027.md) | | Share repurchases | $m | [46.0 d](/filings/0000028917-24-000030.md) | [18.2 d](/filings/0000028917-26-000006.md) | not reported | not reported | not reported | [16.0 d](/filings/0000028917-26-000006.md) | [98.0](/filings/0000028917-26-000019.md) | [9.8 d](/filings/0000028917-26-000027.md) | [0.0 d](/filings/0000028917-25-000032.md) | [0.0 d](/filings/0000028917-26-000006.md) | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-10-29) | Q1 FY2023 (2023-04-29) | Q2 FY2023 (2023-07-29) | Q3 FY2023 (2023-10-28) | Q1 FY2024 (2024-05-04) | Q2 FY2024 (2024-08-03) | Q3 FY2024 (2024-11-02) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [17.1](/filings/0000028917-23-000034.md) | [17.0](/filings/0000028917-24-000022.md) | [16.5](/filings/0000028917-24-000026.md) | [16.4](/filings/0000028917-24-000030.md) | [16.2](/filings/0000028917-25-000019.md) | [16.2](/filings/0000028917-25-000025.md) | [16.1](/filings/0000028917-25-000032.md) | [15.8](/filings/0000028917-26-000019.md) | [15.6](/filings/0000028917-26-000027.md) | [15.6](/filings/0000028917-25-000032.md) | [15.6](/filings/0000028917-26-000019.md) | [15.6](/filings/0000028917-26-000027.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.